INFECTION PREVENTION IN RUSSIA

  • 01.12.2023
  • 16:15–17:45
  • VDNH, 55 pavilion, Small hall 3
The COVID-19 pandemic has become a vivid example of why preventing infections, with the maximum consolidation of the efforts of medical services, biotechnology companies, and the public, has become such a strategically important focus of Russia’s development. The pandemic resulted in the rapid development and registration of diagnostic systems and vaccines that saved numerous human lives. In an effort to increase immunization and maintain the working capacity of the population, a plan was approved at the federal level to implement a strategy to develop preventive immunization against infectious diseases. The creation of new tools to monitor the epidemiological situation, improvements to primary healthcare, updates to the national calendar of preventive vaccinations, and the establishment of a full cycle of vaccine production have all had a positive impact on life expectancy and strengthening collective immunity, as well as increasing the economic efficiency of the state. What tools does Russia have today to monitor the epidemiological situation and prevent emergencies as a result of infectious diseases? How can primary healthcare mechanisms be improved to effectively vaccinate the population? How can we overcome challenges associated with preventing infections among the country’s residents? What funding and production tools do companies need to develop to help accelerate preventive immunization in the face of a global biological threat?